Cogent Biosciences Grants 25,500 Options and 18,700 RSUs to Six New Hires
COGT•Cogent Biosciences will present at the Jefferies Global Healthcare Conference on June 3 with a live webcast. Its board approved inducement equity awards totaling 25,500 options and 18,700 RSUs for six new hires under Nasdaq rule 5635(c)(4), vesting over four years.
1. Conference Participation
Cogent Biosciences will present at the Jefferies Global Healthcare Conference in New York on June 3 at 11:05 a.m. ET. A live webcast will be available on the company’s investor website, with a replay archived for up to 30 days.
2. Inducement Equity Awards
On May 26 the Compensation Committee approved inducement awards to six new employees under the 2020 Inducement Plan and Nasdaq Listing Rule 5635(c)(4). The grants include nonqualified options for 25,500 shares and 18,700 RSUs, with options exercisable over 10 years at the closing price on the grant date and vesting 25% after one year then monthly over 36 months; RSUs vest 25% annually over four years.
